Literature DB >> 11128419

Nephrogenic diabetes insipidus.

P M Deen1, N Marr, E J Kamsteeg, B W van Balkom.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11128419     DOI： 10.1097/00041552-200011000-00001

Source DB:  PubMed          Journal:  Curr Opin Nephrol Hypertens        ISSN： 1062-4821            Impact factor:   2.894


× No keyword cloud information.
  10 in total

Review 1.  Osmotic stress signaling and osmoadaptation in yeasts.

Authors:  Stefan Hohmann
Journal:  Microbiol Mol Biol Rev       Date:  2002-06       Impact factor: 11.056

2.  Rescue of vasopressin V2 receptor mutants by chemical chaperones: specificity and mechanism.

Authors:  J H Robben; M Sze; N V A M Knoers; P M T Deen
Journal:  Mol Biol Cell       Date:  2005-11-02       Impact factor: 4.138

Review 3.  Vasopressin and the regulation of aquaporin-2.

Authors:  Justin L L Wilson; Carlos A Miranda; Mark A Knepper
Journal:  Clin Exp Nephrol       Date:  2013-04-13       Impact factor: 2.801

4.  Characterization of D150E and G196D aquaporin-2 mutations responsible for nephrogenic diabetes insipidus: importance of a mild phenotype.

Authors:  Cécile Guyon; Yoann Lussier; Pierre Bissonnette; Alexandre Leduc-Nadeau; Michèle Lonergan; Marie-Françoise Arthus; Rafael Bedoya Perez; Anatoly Tiulpakov; Jean-Yves Lapointe; Daniel G Bichet
Journal:  Am J Physiol Renal Physiol       Date:  2009-05-20

Review 5.  Pharmacological chaperoning: a primer on mechanism and pharmacology.

Authors:  Nancy J Leidenheimer; Katelyn G Ryder
Journal:  Pharmacol Res       Date:  2014-02-14       Impact factor: 7.658

Review 6.  Aquaporin-2 regulation in health and disease.

Authors:  M Judith Radin; Ming-Jiun Yu; Lene Stoedkilde; R Lance Miller; Jason D Hoffert; Jorgen Frokiaer; Trairak Pisitkun; Mark A Knepper
Journal:  Vet Clin Pathol       Date:  2012-11-06       Impact factor: 1.180

Review 7.  Congenital nephrogenic diabetes insipidus with end-stage renal disease.

Authors:  Hyun Ho Ryu; Jong Hoon Chung; Byung Chul Shin; Hyun Lee Kim
Journal:  Korean J Intern Med       Date:  2015-02-27       Impact factor: 2.884

Review 8.  A novel therapeutic effect of statins on nephrogenic diabetes insipidus.

Authors:  Leonilde Bonfrate; Giuseppe Procino; David Q-H Wang; Maria Svelto; Piero Portincasa
Journal:  J Cell Mol Med       Date:  2015-01-16       Impact factor: 5.310

Review 9.  Assistance for Folding of Disease-Causing Plasma Membrane Proteins.

Authors:  Karina Juarez-Navarro; Victor M Ayala-Garcia; Estela Ruiz-Baca; Ivan Meneses-Morales; Jose Luis Rios-Banuelos; Angelica Lopez-Rodriguez
Journal:  Biomolecules       Date:  2020-05-07

10.  Characterization of five novel vasopressin V2 receptor mutants causing nephrogenic diabetes insipidus reveals a role of tolvaptan for M272R-V2R mutation.

Authors:  Federica Prosperi; Yoko Suzumoto; Pierluigi Marzuillo; Vincenzo Costanzo; Sabina Jelen; Anna Iervolino; Stefano Guarino; Angela La Manna; Emanuele Miraglia Del Giudice; Alessandra F Perna; Miriam Zacchia; Emmanuelle Cordat; Giovambattista Capasso; Francesco Trepiccione
Journal:  Sci Rep       Date:  2020-10-02       Impact factor: 4.379
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.